07.26.24 -- How Eli Lilly's Making Peptides Faster And More Reliably

The logistics of decoupling drug substance manufacturing from final drug product formulation is now possible using integrated single-use freeze-thaw assemblies that incorporate reliable components.

By proactively addressing recurring deficiencies in design controls and risk management, manufacturers can ensure FDA compliance and prioritize patient safety and device effectiveness.

Review advice to pharma companies on three key areas of auto-injector device development: patient-centered design, container and device considerations, and manufacturing partner selection.

Here, we provide a lyophilization process overview that dives deeper into freeze-drying and reviews drying pressure, temperatures, cycle optimization, scale-up considerations, and storage.

How can you reduce tooling wear and problems caused by abrasive ingredients during your tablet manufacturing process?

Find solutions to five key challenges of quality assurance and information to help you identify which product inspection products can best support your application.

The pharmaceutical industry is undergoing a transformative shift from batch to continuous flow processes, enabling enhanced efficiency and safety as well as improved sustainability.

Building more sustainable practices across the pharmaceutical industry takes a collaborative and transparent effort. One leading CDMO is leveraging its solvent recovery efforts to yield major strides.

How can you address the decontamination challenges associated with isolated fill-finish operations? New innovations are being implemented to ensure superior sporicidal reduction and operational safety.

Take a deeper look at the challenges and solutions involved in creating a child-friendly medication delivery system, and learn about the importance of collaboration and meticulous scientific processes.

Using a contract or toll manufacturer in the specialty and custom chemical industry can be viewed as a quality and supply chain risk. Discover what equipment sourcing strategies can mitigate those risks.

Examine highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

Watch this discussion to learn about resistance testing and using it to control and monitor incoming biological indicators (BI).

Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.